it is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. it is a sympathomimetic amine structurally similar to amphetamine with anorexiant activity. it stimulates the central nervous system and increases the release of norepinephrine and dopamine from nerve terminals and inhibits their uptake. This suppresses appetite, increases motor activity, causes euphoria, mental alertness and excitement. This drug may also cause an increase in heart rate and blood pressure. it is used in the treatment of obesity. 
